Immediate Impact

65 standout
Sub-graph 1 of 21

Citing Papers

Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
2025 Standout
3 intermediate papers

Works of Shadi Hamdeh being referenced

Rates of and Factors Associated With Placebo Response in Trials of Pharmacotherapies for Nonalcoholic Steatohepatitis: Systematic Review and Meta-analysis
2018

Author Peers

Author Last Decade Papers Cites
Shadi Hamdeh 49 79 238 217 109 25 593
Donnie Funch 16 103 212 60 95 19 676
Luca Moroni 71 141 154 69 25 39 619
Violetta Kapsimali 49 78 98 99 28 43 686
M. Le Bras 17 238 176 78 80 45 518
Stebbins B. Chandor 88 124 134 75 10 36 644
Haolong Li 12 37 100 250 18 55 574
Michael Corkill 41 73 75 78 49 20 627
Jenna Gustafson 17 79 255 151 21 17 530
I. Delèvaux 26 157 221 50 52 38 589
Álvaro Danza 38 37 66 71 25 25 731

All Works

Loading papers...

Rankless by CCL
2026